Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10844126
APP PUB NO 20190127473A1
SERIAL NO

16050513

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is based, in part, on the discovery of galectin 1 (Gal1) epitopes against which anti-Gal1 agents can neutralize Gal1 function, as well as anti-Gal1 agents and methods useful for neutralizing Gal1 function.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANA-FARBER CANCER INSTITUTE INC44 BINNEY STREET BOSTON MA 02115

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ouyang, Jing Sharon, US 19 46
Rodig, Scott J Westwood, US 12 112
Shipp, Margaret A Wellesley, US 19 123

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 24, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00